nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—VDR—epilepsy syndrome	0.318	1	CbGaD
Paricalcitol—UGT1A4—Lamotrigine—epilepsy syndrome	0.168	0.357	CbGbCtD
Paricalcitol—UGT1A4—Midazolam—epilepsy syndrome	0.114	0.242	CbGbCtD
Paricalcitol—UGT1A4—Valproic Acid—epilepsy syndrome	0.0863	0.183	CbGbCtD
Paricalcitol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00902	0.0192	CbGbCtD
Paricalcitol—CYP3A4—Trimethadione—epilepsy syndrome	0.00839	0.0178	CbGbCtD
Paricalcitol—CYP3A4—Felbamate—epilepsy syndrome	0.00839	0.0178	CbGbCtD
Paricalcitol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00788	0.0167	CbGbCtD
Paricalcitol—CYP3A4—Clonazepam—epilepsy syndrome	0.00713	0.0151	CbGbCtD
Paricalcitol—CYP3A4—Clobazam—epilepsy syndrome	0.00684	0.0145	CbGbCtD
Paricalcitol—CYP3A4—Rufinamide—epilepsy syndrome	0.00581	0.0123	CbGbCtD
Paricalcitol—CYP3A4—Carbamazepine—epilepsy syndrome	0.00566	0.012	CbGbCtD
Paricalcitol—CYP3A4—Primidone—epilepsy syndrome	0.00529	0.0112	CbGbCtD
Paricalcitol—CYP3A4—Phenytoin—epilepsy syndrome	0.00508	0.0108	CbGbCtD
Paricalcitol—CYP3A4—Propofol—epilepsy syndrome	0.00474	0.0101	CbGbCtD
Paricalcitol—CYP3A4—Acetazolamide—epilepsy syndrome	0.00453	0.00962	CbGbCtD
Paricalcitol—CYP3A4—Phenobarbital—epilepsy syndrome	0.00453	0.00962	CbGbCtD
Paricalcitol—CYP3A4—Midazolam—epilepsy syndrome	0.00447	0.00948	CbGbCtD
Paricalcitol—CYP3A4—Diazepam—epilepsy syndrome	0.00429	0.00912	CbGbCtD
Paricalcitol—CYP3A4—Zonisamide—epilepsy syndrome	0.00419	0.0089	CbGbCtD
Paricalcitol—CYP3A4—Valproic Acid—epilepsy syndrome	0.00338	0.00719	CbGbCtD
Paricalcitol—CYP3A4—Topiramate—epilepsy syndrome	0.00305	0.00649	CbGbCtD
Paricalcitol—Dihydrotachysterol—VDR—epilepsy syndrome	0.000748	0.2	CrCbGaD
Paricalcitol—Calcidiol—VDR—epilepsy syndrome	0.000482	0.129	CrCbGaD
Paricalcitol—Alfacalcidol—VDR—epilepsy syndrome	0.000482	0.129	CrCbGaD
Paricalcitol—Calcipotriol—VDR—epilepsy syndrome	0.000482	0.129	CrCbGaD
Paricalcitol—Calcitriol—VDR—epilepsy syndrome	0.00043	0.115	CrCbGaD
Paricalcitol—Ergocalciferol—VDR—epilepsy syndrome	0.000343	0.0919	CrCbGaD
Paricalcitol—Cholecalciferol—CYP11A1—epilepsy syndrome	0.000306	0.0818	CrCbGaD
Paricalcitol—Cholecalciferol—VDR—epilepsy syndrome	0.00026	0.0697	CrCbGaD
Paricalcitol—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	0.000123	0.00321	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	0.000123	0.00321	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP2D6—epilepsy syndrome	0.000121	0.00318	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.000119	0.00313	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000119	0.00312	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000118	0.00309	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—HBEGF—epilepsy syndrome	0.000117	0.00308	CbGpPWpGaD
Paricalcitol—Cholecalciferol—CYP2C19—epilepsy syndrome	0.000117	0.0312	CrCbGaD
Paricalcitol—CYP24A1—Metabolism—CA13—epilepsy syndrome	0.000116	0.00303	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	0.000114	0.00298	CbGpPWpGaD
Paricalcitol—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	0.00011	0.00288	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	0.00011	0.00288	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000106	0.00277	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—HMOX1—epilepsy syndrome	0.000103	0.00269	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000102	0.00266	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—AKT1—epilepsy syndrome	0.000101	0.00264	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—GPX1—epilepsy syndrome	9.93e-05	0.0026	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	9.68e-05	0.00254	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—WARS—epilepsy syndrome	9.44e-05	0.00247	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	9.3e-05	0.00244	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CA13—epilepsy syndrome	9.24e-05	0.00242	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	9.18e-05	0.00241	CbGpPWpGaD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	8.94e-05	0.00234	CbGpPWpGaD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	8.92e-05	0.00234	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	8.89e-05	0.00233	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FAR1—epilepsy syndrome	8.76e-05	0.0023	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CERS1—epilepsy syndrome	8.76e-05	0.0023	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GLUD1—epilepsy syndrome	8.76e-05	0.0023	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PDXK—epilepsy syndrome	8.76e-05	0.0023	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—L2HGDH—epilepsy syndrome	8.76e-05	0.0023	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ADK—epilepsy syndrome	8.76e-05	0.0023	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TSC2—epilepsy syndrome	8.72e-05	0.00229	CbGpPWpGaD
Paricalcitol—Cholecalciferol—CYP2D6—epilepsy syndrome	8.65e-05	0.0232	CrCbGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	8.42e-05	0.00221	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	8.17e-05	0.00214	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PNPO—epilepsy syndrome	8.01e-05	0.0021	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GAMT—epilepsy syndrome	8.01e-05	0.0021	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—EPM2A—epilepsy syndrome	8.01e-05	0.0021	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NHLRC1—epilepsy syndrome	8.01e-05	0.0021	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CA4—epilepsy syndrome	7.44e-05	0.00195	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—QDPR—epilepsy syndrome	7.44e-05	0.00195	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—POMC—epilepsy syndrome	7.42e-05	0.00195	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—QARS—epilepsy syndrome	7.15e-05	0.00187	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ADK—epilepsy syndrome	7e-05	0.00184	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—L2HGDH—epilepsy syndrome	7e-05	0.00184	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CERS1—epilepsy syndrome	7e-05	0.00184	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—COX3—epilepsy syndrome	7e-05	0.00184	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PDXK—epilepsy syndrome	7e-05	0.00184	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FAR1—epilepsy syndrome	7e-05	0.00184	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GLUD1—epilepsy syndrome	7e-05	0.00184	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PFKL—epilepsy syndrome	6.64e-05	0.00174	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLCO1A2—epilepsy syndrome	6.64e-05	0.00174	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CACNA2D2—epilepsy syndrome	6.64e-05	0.00174	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—KCNB1—epilepsy syndrome	6.64e-05	0.00174	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC6A8—epilepsy syndrome	6.64e-05	0.00174	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	6.55e-05	0.00172	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	6.49e-05	0.0017	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6.45e-05	0.00169	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NHLRC1—epilepsy syndrome	6.4e-05	0.00168	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—EPM2A—epilepsy syndrome	6.4e-05	0.00168	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PNPO—epilepsy syndrome	6.4e-05	0.00168	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GAMT—epilepsy syndrome	6.4e-05	0.00168	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BCL2—epilepsy syndrome	6.16e-05	0.00161	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—UPB1—epilepsy syndrome	6.07e-05	0.00159	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ATIC—epilepsy syndrome	6.07e-05	0.00159	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NEU1—epilepsy syndrome	6.07e-05	0.00159	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—QDPR—epilepsy syndrome	5.95e-05	0.00156	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CA4—epilepsy syndrome	5.95e-05	0.00156	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—POMC—epilepsy syndrome	5.93e-05	0.00156	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HSD17B4—epilepsy syndrome	5.84e-05	0.00153	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EIF2B5—epilepsy syndrome	5.72e-05	0.0015	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GBE1—epilepsy syndrome	5.64e-05	0.00148	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPP1R3C—epilepsy syndrome	5.64e-05	0.00148	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—COX3—epilepsy syndrome	5.6e-05	0.00147	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.51e-05	0.00145	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	5.39e-05	0.00141	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PFKL—epilepsy syndrome	5.3e-05	0.00139	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLCO1A2—epilepsy syndrome	5.3e-05	0.00139	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CACNA2D2—epilepsy syndrome	5.3e-05	0.00139	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—KCNB1—epilepsy syndrome	5.3e-05	0.00139	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC6A8—epilepsy syndrome	5.3e-05	0.00139	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ASAH1—epilepsy syndrome	5.3e-05	0.00139	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—JUN—epilepsy syndrome	5.27e-05	0.00138	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—JUNB—epilepsy syndrome	5.21e-05	0.00136	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—TFAM—epilepsy syndrome	5.17e-05	0.00136	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—STXBP1—epilepsy syndrome	5.16e-05	0.00135	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	5.13e-05	0.00135	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	5.12e-05	0.00134	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	5.09e-05	0.00133	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	5.06e-05	0.00133	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NT5E—epilepsy syndrome	5.03e-05	0.00132	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALAD—epilepsy syndrome	5.03e-05	0.00132	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	5.02e-05	0.00132	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	4.99e-05	0.00131	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NEU1—epilepsy syndrome	4.85e-05	0.00127	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—UPB1—epilepsy syndrome	4.85e-05	0.00127	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ATIC—epilepsy syndrome	4.85e-05	0.00127	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CACNA1A—epilepsy syndrome	4.8e-05	0.00126	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALDH7A1—epilepsy syndrome	4.8e-05	0.00126	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ST3GAL3—epilepsy syndrome	4.69e-05	0.00123	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD17B4—epilepsy syndrome	4.67e-05	0.00122	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ADSL—epilepsy syndrome	4.6e-05	0.00121	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	4.57e-05	0.0012	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	4.55e-05	0.00119	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GLUL—epilepsy syndrome	4.51e-05	0.00118	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GBE1—epilepsy syndrome	4.51e-05	0.00118	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPP1R3C—epilepsy syndrome	4.51e-05	0.00118	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	4.51e-05	0.00118	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SNRPE—epilepsy syndrome	4.46e-05	0.00117	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CACNA1D—epilepsy syndrome	4.43e-05	0.00116	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ASAH1—epilepsy syndrome	4.24e-05	0.00111	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	4.14e-05	0.00109	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TXNRD1—epilepsy syndrome	4.14e-05	0.00109	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	4.13e-05	0.00108	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—STXBP1—epilepsy syndrome	4.13e-05	0.00108	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	4.1e-05	0.00108	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AQP1—epilepsy syndrome	4.02e-05	0.00105	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALAD—epilepsy syndrome	4.02e-05	0.00105	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NT5E—epilepsy syndrome	4.02e-05	0.00105	CbGpPWpGaD
Paricalcitol—Headache—Vigabatrin—epilepsy syndrome	3.95e-05	0.000233	CcSEcCtD
Paricalcitol—Hypertension—Pregabalin—epilepsy syndrome	3.95e-05	0.000233	CcSEcCtD
Paricalcitol—Vomiting—Diazepam—epilepsy syndrome	3.95e-05	0.000233	CcSEcCtD
Paricalcitol—Anorexia—Valproic Acid—epilepsy syndrome	3.93e-05	0.000232	CcSEcCtD
Paricalcitol—Rash—Diazepam—epilepsy syndrome	3.91e-05	0.000231	CcSEcCtD
Paricalcitol—Dermatitis—Diazepam—epilepsy syndrome	3.91e-05	0.000231	CcSEcCtD
Paricalcitol—Myalgia—Pregabalin—epilepsy syndrome	3.89e-05	0.00023	CcSEcCtD
Paricalcitol—Chest pain—Pregabalin—epilepsy syndrome	3.89e-05	0.00023	CcSEcCtD
Paricalcitol—Arthralgia—Pregabalin—epilepsy syndrome	3.89e-05	0.00023	CcSEcCtD
Paricalcitol—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.89e-05	0.000229	CcSEcCtD
Paricalcitol—Dizziness—Zonisamide—epilepsy syndrome	3.89e-05	0.000229	CcSEcCtD
Paricalcitol—Headache—Diazepam—epilepsy syndrome	3.89e-05	0.000229	CcSEcCtD
Paricalcitol—Anxiety—Pregabalin—epilepsy syndrome	3.88e-05	0.000229	CcSEcCtD
Paricalcitol—Diarrhoea—Clonazepam—epilepsy syndrome	3.88e-05	0.000229	CcSEcCtD
Paricalcitol—Anaemia—Gabapentin—epilepsy syndrome	3.87e-05	0.000229	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.86e-05	0.000228	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.86e-05	0.00101	CbGpPWpGaD
Paricalcitol—Hypotension—Valproic Acid—epilepsy syndrome	3.85e-05	0.000227	CcSEcCtD
Paricalcitol—Asthenia—Carbamazepine—epilepsy syndrome	3.85e-05	0.000227	CcSEcCtD
Paricalcitol—Agitation—Gabapentin—epilepsy syndrome	3.85e-05	0.000227	CcSEcCtD
Paricalcitol—Diarrhoea—Phenytoin—epilepsy syndrome	3.85e-05	0.000227	CcSEcCtD
Paricalcitol—Discomfort—Pregabalin—epilepsy syndrome	3.84e-05	0.000227	CcSEcCtD
Paricalcitol—Nausea—Fosphenytoin—epilepsy syndrome	3.84e-05	0.000227	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ALDH7A1—epilepsy syndrome	3.84e-05	0.00101	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CACNA1A—epilepsy syndrome	3.84e-05	0.00101	CbGpPWpGaD
Paricalcitol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.83e-05	0.000226	CcSEcCtD
Paricalcitol—Angioedema—Gabapentin—epilepsy syndrome	3.83e-05	0.000226	CcSEcCtD
Paricalcitol—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.82e-05	0.000226	CcSEcCtD
Paricalcitol—Vomiting—Felbamate—epilepsy syndrome	3.82e-05	0.000225	CcSEcCtD
Paricalcitol—Dry mouth—Pregabalin—epilepsy syndrome	3.8e-05	0.000225	CcSEcCtD
Paricalcitol—Pruritus—Carbamazepine—epilepsy syndrome	3.8e-05	0.000224	CcSEcCtD
Paricalcitol—Rash—Felbamate—epilepsy syndrome	3.79e-05	0.000223	CcSEcCtD
Paricalcitol—Eye disorder—Topiramate—epilepsy syndrome	3.78e-05	0.000223	CcSEcCtD
Paricalcitol—Dermatitis—Felbamate—epilepsy syndrome	3.78e-05	0.000223	CcSEcCtD
Paricalcitol—Malaise—Gabapentin—epilepsy syndrome	3.78e-05	0.000223	CcSEcCtD
Paricalcitol—Vertigo—Gabapentin—epilepsy syndrome	3.76e-05	0.000222	CcSEcCtD
Paricalcitol—Headache—Felbamate—epilepsy syndrome	3.76e-05	0.000222	CcSEcCtD
Paricalcitol—Confusional state—Pregabalin—epilepsy syndrome	3.76e-05	0.000222	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.76e-05	0.000222	CcSEcCtD
Paricalcitol—Cardiac disorder—Topiramate—epilepsy syndrome	3.76e-05	0.000222	CcSEcCtD
Paricalcitol—Syncope—Gabapentin—epilepsy syndrome	3.76e-05	0.000222	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ST3GAL3—epilepsy syndrome	3.75e-05	0.000984	CbGpPWpGaD
Paricalcitol—Leukopenia—Gabapentin—epilepsy syndrome	3.75e-05	0.000221	CcSEcCtD
Paricalcitol—Dizziness—Clonazepam—epilepsy syndrome	3.75e-05	0.000221	CcSEcCtD
Paricalcitol—Nausea—Vigabatrin—epilepsy syndrome	3.74e-05	0.000221	CcSEcCtD
Paricalcitol—Vomiting—Zonisamide—epilepsy syndrome	3.74e-05	0.000221	CcSEcCtD
Paricalcitol—Insomnia—Valproic Acid—epilepsy syndrome	3.73e-05	0.00022	CcSEcCtD
Paricalcitol—Oedema—Pregabalin—epilepsy syndrome	3.73e-05	0.00022	CcSEcCtD
Paricalcitol—Asthenia—Lamotrigine—epilepsy syndrome	3.72e-05	0.00022	CcSEcCtD
Paricalcitol—Dizziness—Phenytoin—epilepsy syndrome	3.72e-05	0.00022	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	3.72e-05	0.000975	CbGpPWpGaD
Paricalcitol—Rash—Zonisamide—epilepsy syndrome	3.71e-05	0.000219	CcSEcCtD
Paricalcitol—Infection—Pregabalin—epilepsy syndrome	3.71e-05	0.000219	CcSEcCtD
Paricalcitol—Paraesthesia—Valproic Acid—epilepsy syndrome	3.7e-05	0.000219	CcSEcCtD
Paricalcitol—Palpitations—Gabapentin—epilepsy syndrome	3.7e-05	0.000219	CcSEcCtD
Paricalcitol—Dermatitis—Zonisamide—epilepsy syndrome	3.7e-05	0.000219	CcSEcCtD
Paricalcitol—Dizziness—Oxcarbazepine—epilepsy syndrome	3.7e-05	0.000218	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.7e-05	0.00097	CbGpPWpGaD
Paricalcitol—Nausea—Diazepam—epilepsy syndrome	3.69e-05	0.000218	CcSEcCtD
Paricalcitol—Loss of consciousness—Gabapentin—epilepsy syndrome	3.68e-05	0.000217	CcSEcCtD
Paricalcitol—Headache—Zonisamide—epilepsy syndrome	3.68e-05	0.000217	CcSEcCtD
Paricalcitol—Dyspnoea—Valproic Acid—epilepsy syndrome	3.68e-05	0.000217	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ADSL—epilepsy syndrome	3.68e-05	0.000964	CbGpPWpGaD
Paricalcitol—Diarrhoea—Carbamazepine—epilepsy syndrome	3.68e-05	0.000217	CcSEcCtD
Paricalcitol—Angiopathy—Topiramate—epilepsy syndrome	3.67e-05	0.000217	CcSEcCtD
Paricalcitol—Pruritus—Lamotrigine—epilepsy syndrome	3.67e-05	0.000217	CcSEcCtD
Paricalcitol—Shock—Pregabalin—epilepsy syndrome	3.67e-05	0.000217	CcSEcCtD
Paricalcitol—Somnolence—Valproic Acid—epilepsy syndrome	3.67e-05	0.000216	CcSEcCtD
Paricalcitol—Immune system disorder—Topiramate—epilepsy syndrome	3.66e-05	0.000216	CcSEcCtD
Paricalcitol—Nervous system disorder—Pregabalin—epilepsy syndrome	3.66e-05	0.000216	CcSEcCtD
Paricalcitol—Cough—Gabapentin—epilepsy syndrome	3.66e-05	0.000216	CcSEcCtD
Paricalcitol—Mediastinal disorder—Topiramate—epilepsy syndrome	3.65e-05	0.000215	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CHRM3—epilepsy syndrome	3.64e-05	0.000953	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—KCNJ11—epilepsy syndrome	3.64e-05	0.000953	CbGpPWpGaD
Paricalcitol—Chills—Topiramate—epilepsy syndrome	3.63e-05	0.000214	CcSEcCtD
Paricalcitol—Dyspepsia—Valproic Acid—epilepsy syndrome	3.63e-05	0.000214	CcSEcCtD
Paricalcitol—Skin disorder—Pregabalin—epilepsy syndrome	3.62e-05	0.000214	CcSEcCtD
Paricalcitol—Hypertension—Gabapentin—epilepsy syndrome	3.62e-05	0.000214	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GLUL—epilepsy syndrome	3.61e-05	0.000945	CbGpPWpGaD
Paricalcitol—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.61e-05	0.000213	CcSEcCtD
Paricalcitol—Vomiting—Clonazepam—epilepsy syndrome	3.6e-05	0.000213	CcSEcCtD
Paricalcitol—Decreased appetite—Valproic Acid—epilepsy syndrome	3.59e-05	0.000212	CcSEcCtD
Paricalcitol—Alopecia—Topiramate—epilepsy syndrome	3.58e-05	0.000211	CcSEcCtD
Paricalcitol—Vomiting—Phenytoin—epilepsy syndrome	3.58e-05	0.000211	CcSEcCtD
Paricalcitol—Rash—Clonazepam—epilepsy syndrome	3.57e-05	0.000211	CcSEcCtD
Paricalcitol—Dermatitis—Clonazepam—epilepsy syndrome	3.57e-05	0.000211	CcSEcCtD
Paricalcitol—Chest pain—Gabapentin—epilepsy syndrome	3.57e-05	0.000211	CcSEcCtD
Paricalcitol—Myalgia—Gabapentin—epilepsy syndrome	3.57e-05	0.000211	CcSEcCtD
Paricalcitol—Arthralgia—Gabapentin—epilepsy syndrome	3.57e-05	0.000211	CcSEcCtD
Paricalcitol—Nausea—Felbamate—epilepsy syndrome	3.57e-05	0.000211	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.56e-05	0.00021	CcSEcCtD
Paricalcitol—Vomiting—Oxcarbazepine—epilepsy syndrome	3.56e-05	0.00021	CcSEcCtD
Paricalcitol—Fatigue—Valproic Acid—epilepsy syndrome	3.56e-05	0.00021	CcSEcCtD
Paricalcitol—Anxiety—Gabapentin—epilepsy syndrome	3.56e-05	0.00021	CcSEcCtD
Paricalcitol—Anorexia—Pregabalin—epilepsy syndrome	3.56e-05	0.00021	CcSEcCtD
Paricalcitol—Dizziness—Carbamazepine—epilepsy syndrome	3.55e-05	0.00021	CcSEcCtD
Paricalcitol—Diarrhoea—Lamotrigine—epilepsy syndrome	3.55e-05	0.00021	CcSEcCtD
Paricalcitol—Headache—Clonazepam—epilepsy syndrome	3.55e-05	0.000209	CcSEcCtD
Paricalcitol—Rash—Phenytoin—epilepsy syndrome	3.55e-05	0.000209	CcSEcCtD
Paricalcitol—Mental disorder—Topiramate—epilepsy syndrome	3.55e-05	0.000209	CcSEcCtD
Paricalcitol—Dermatitis—Phenytoin—epilepsy syndrome	3.54e-05	0.000209	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.54e-05	0.000209	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CACNA1D—epilepsy syndrome	3.54e-05	0.000928	CbGpPWpGaD
Paricalcitol—Rash—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.000208	CcSEcCtD
Paricalcitol—Pain—Valproic Acid—epilepsy syndrome	3.53e-05	0.000208	CcSEcCtD
Paricalcitol—Constipation—Valproic Acid—epilepsy syndrome	3.53e-05	0.000208	CcSEcCtD
Paricalcitol—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.000208	CcSEcCtD
Paricalcitol—Headache—Phenytoin—epilepsy syndrome	3.53e-05	0.000208	CcSEcCtD
Paricalcitol—Malnutrition—Topiramate—epilepsy syndrome	3.53e-05	0.000208	CcSEcCtD
Paricalcitol—Discomfort—Gabapentin—epilepsy syndrome	3.52e-05	0.000208	CcSEcCtD
Paricalcitol—Headache—Oxcarbazepine—epilepsy syndrome	3.51e-05	0.000207	CcSEcCtD
Paricalcitol—Nausea—Zonisamide—epilepsy syndrome	3.49e-05	0.000206	CcSEcCtD
Paricalcitol—Dry mouth—Gabapentin—epilepsy syndrome	3.49e-05	0.000206	CcSEcCtD
Paricalcitol—Hypotension—Pregabalin—epilepsy syndrome	3.48e-05	0.000206	CcSEcCtD
Paricalcitol—Tension—Topiramate—epilepsy syndrome	3.46e-05	0.000204	CcSEcCtD
Paricalcitol—Dysgeusia—Topiramate—epilepsy syndrome	3.45e-05	0.000204	CcSEcCtD
Paricalcitol—Confusional state—Gabapentin—epilepsy syndrome	3.45e-05	0.000204	CcSEcCtD
Paricalcitol—Dizziness—Lamotrigine—epilepsy syndrome	3.43e-05	0.000203	CcSEcCtD
Paricalcitol—Nervousness—Topiramate—epilepsy syndrome	3.42e-05	0.000202	CcSEcCtD
Paricalcitol—Oedema—Gabapentin—epilepsy syndrome	3.42e-05	0.000202	CcSEcCtD
Paricalcitol—Vomiting—Carbamazepine—epilepsy syndrome	3.42e-05	0.000202	CcSEcCtD
Paricalcitol—Back pain—Topiramate—epilepsy syndrome	3.41e-05	0.000201	CcSEcCtD
Paricalcitol—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.4e-05	0.000201	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.4e-05	0.000201	CcSEcCtD
Paricalcitol—Infection—Gabapentin—epilepsy syndrome	3.4e-05	0.000201	CcSEcCtD
Paricalcitol—Muscle spasms—Topiramate—epilepsy syndrome	3.39e-05	0.0002	CcSEcCtD
Paricalcitol—Rash—Carbamazepine—epilepsy syndrome	3.39e-05	0.0002	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.39e-05	0.000888	CbGpPWpGaD
Paricalcitol—Dermatitis—Carbamazepine—epilepsy syndrome	3.38e-05	0.0002	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.37e-05	0.000199	CcSEcCtD
Paricalcitol—Insomnia—Pregabalin—epilepsy syndrome	3.37e-05	0.000199	CcSEcCtD
Paricalcitol—Nausea—Clonazepam—epilepsy syndrome	3.37e-05	0.000199	CcSEcCtD
Paricalcitol—Headache—Carbamazepine—epilepsy syndrome	3.37e-05	0.000199	CcSEcCtD
Paricalcitol—Shock—Gabapentin—epilepsy syndrome	3.36e-05	0.000199	CcSEcCtD
Paricalcitol—Nervous system disorder—Gabapentin—epilepsy syndrome	3.35e-05	0.000198	CcSEcCtD
Paricalcitol—Paraesthesia—Pregabalin—epilepsy syndrome	3.35e-05	0.000198	CcSEcCtD
Paricalcitol—Nausea—Phenytoin—epilepsy syndrome	3.34e-05	0.000197	CcSEcCtD
Paricalcitol—Dyspnoea—Pregabalin—epilepsy syndrome	3.33e-05	0.000196	CcSEcCtD
Paricalcitol—Nausea—Oxcarbazepine—epilepsy syndrome	3.32e-05	0.000196	CcSEcCtD
Paricalcitol—Skin disorder—Gabapentin—epilepsy syndrome	3.32e-05	0.000196	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.32e-05	0.00087	CbGpPWpGaD
Paricalcitol—Somnolence—Pregabalin—epilepsy syndrome	3.32e-05	0.000196	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—TXNRD1—epilepsy syndrome	3.31e-05	0.000868	CbGpPWpGaD
Paricalcitol—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.31e-05	0.000195	CcSEcCtD
Paricalcitol—Vomiting—Lamotrigine—epilepsy syndrome	3.3e-05	0.000195	CcSEcCtD
Paricalcitol—Urticaria—Valproic Acid—epilepsy syndrome	3.28e-05	0.000193	CcSEcCtD
Paricalcitol—Rash—Lamotrigine—epilepsy syndrome	3.27e-05	0.000193	CcSEcCtD
Paricalcitol—Ill-defined disorder—Topiramate—epilepsy syndrome	3.27e-05	0.000193	CcSEcCtD
Paricalcitol—Dermatitis—Lamotrigine—epilepsy syndrome	3.27e-05	0.000193	CcSEcCtD
Paricalcitol—Abdominal pain—Valproic Acid—epilepsy syndrome	3.26e-05	0.000192	CcSEcCtD
Paricalcitol—Body temperature increased—Valproic Acid—epilepsy syndrome	3.26e-05	0.000192	CcSEcCtD
Paricalcitol—Anorexia—Gabapentin—epilepsy syndrome	3.26e-05	0.000192	CcSEcCtD
Paricalcitol—Anaemia—Topiramate—epilepsy syndrome	3.26e-05	0.000192	CcSEcCtD
Paricalcitol—Headache—Lamotrigine—epilepsy syndrome	3.25e-05	0.000192	CcSEcCtD
Paricalcitol—Decreased appetite—Pregabalin—epilepsy syndrome	3.24e-05	0.000191	CcSEcCtD
Paricalcitol—Agitation—Topiramate—epilepsy syndrome	3.24e-05	0.000191	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.22e-05	0.00019	CcSEcCtD
Paricalcitol—Fatigue—Pregabalin—epilepsy syndrome	3.22e-05	0.00019	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—AQP1—epilepsy syndrome	3.21e-05	0.000843	CbGpPWpGaD
Paricalcitol—Hypotension—Gabapentin—epilepsy syndrome	3.2e-05	0.000189	CcSEcCtD
Paricalcitol—Nausea—Carbamazepine—epilepsy syndrome	3.19e-05	0.000188	CcSEcCtD
Paricalcitol—Pain—Pregabalin—epilepsy syndrome	3.19e-05	0.000188	CcSEcCtD
Paricalcitol—Constipation—Pregabalin—epilepsy syndrome	3.19e-05	0.000188	CcSEcCtD
Paricalcitol—Malaise—Topiramate—epilepsy syndrome	3.18e-05	0.000188	CcSEcCtD
Paricalcitol—Vertigo—Topiramate—epilepsy syndrome	3.17e-05	0.000187	CcSEcCtD
Paricalcitol—Syncope—Topiramate—epilepsy syndrome	3.16e-05	0.000187	CcSEcCtD
Paricalcitol—Leukopenia—Topiramate—epilepsy syndrome	3.16e-05	0.000186	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.12e-05	0.000184	CcSEcCtD
Paricalcitol—Palpitations—Topiramate—epilepsy syndrome	3.12e-05	0.000184	CcSEcCtD
Paricalcitol—VDR—Gene Expression—EIF2S1—epilepsy syndrome	3.11e-05	0.000816	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Topiramate—epilepsy syndrome	3.1e-05	0.000183	CcSEcCtD
Paricalcitol—Insomnia—Gabapentin—epilepsy syndrome	3.09e-05	0.000183	CcSEcCtD
Paricalcitol—Nausea—Lamotrigine—epilepsy syndrome	3.08e-05	0.000182	CcSEcCtD
Paricalcitol—Cough—Topiramate—epilepsy syndrome	3.08e-05	0.000182	CcSEcCtD
Paricalcitol—Feeling abnormal—Pregabalin—epilepsy syndrome	3.07e-05	0.000181	CcSEcCtD
Paricalcitol—Paraesthesia—Gabapentin—epilepsy syndrome	3.07e-05	0.000181	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.05e-05	0.00018	CcSEcCtD
Paricalcitol—Dyspnoea—Gabapentin—epilepsy syndrome	3.05e-05	0.00018	CcSEcCtD
Paricalcitol—Hypertension—Topiramate—epilepsy syndrome	3.04e-05	0.00018	CcSEcCtD
Paricalcitol—Somnolence—Gabapentin—epilepsy syndrome	3.04e-05	0.000179	CcSEcCtD
Paricalcitol—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.04e-05	0.000179	CcSEcCtD
Paricalcitol—Dyspepsia—Gabapentin—epilepsy syndrome	3.01e-05	0.000178	CcSEcCtD
Paricalcitol—VDR—Gene Expression—HSPB1—epilepsy syndrome	3e-05	0.000787	CbGpPWpGaD
Paricalcitol—Chest pain—Topiramate—epilepsy syndrome	3e-05	0.000177	CcSEcCtD
Paricalcitol—Myalgia—Topiramate—epilepsy syndrome	3e-05	0.000177	CcSEcCtD
Paricalcitol—Arthralgia—Topiramate—epilepsy syndrome	3e-05	0.000177	CcSEcCtD
Paricalcitol—Anxiety—Topiramate—epilepsy syndrome	2.99e-05	0.000177	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.98e-05	0.000176	CcSEcCtD
Paricalcitol—Decreased appetite—Gabapentin—epilepsy syndrome	2.97e-05	0.000175	CcSEcCtD
Paricalcitol—Discomfort—Topiramate—epilepsy syndrome	2.97e-05	0.000175	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ABCG2—epilepsy syndrome	2.96e-05	0.000777	CbGpPWpGaD
Paricalcitol—Urticaria—Pregabalin—epilepsy syndrome	2.96e-05	0.000175	CcSEcCtD
Paricalcitol—Asthenia—Valproic Acid—epilepsy syndrome	2.96e-05	0.000175	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.95e-05	0.000174	CcSEcCtD
Paricalcitol—Fatigue—Gabapentin—epilepsy syndrome	2.95e-05	0.000174	CcSEcCtD
Paricalcitol—Abdominal pain—Pregabalin—epilepsy syndrome	2.95e-05	0.000174	CcSEcCtD
Paricalcitol—Body temperature increased—Pregabalin—epilepsy syndrome	2.95e-05	0.000174	CcSEcCtD
Paricalcitol—Dry mouth—Topiramate—epilepsy syndrome	2.94e-05	0.000173	CcSEcCtD
Paricalcitol—Pain—Gabapentin—epilepsy syndrome	2.92e-05	0.000173	CcSEcCtD
Paricalcitol—Constipation—Gabapentin—epilepsy syndrome	2.92e-05	0.000173	CcSEcCtD
Paricalcitol—Pruritus—Valproic Acid—epilepsy syndrome	2.92e-05	0.000172	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CHRM3—epilepsy syndrome	2.91e-05	0.000762	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—KCNJ11—epilepsy syndrome	2.91e-05	0.000762	CbGpPWpGaD
Paricalcitol—Confusional state—Topiramate—epilepsy syndrome	2.9e-05	0.000171	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP2C19—epilepsy syndrome	2.89e-05	0.000757	CbGpPWpGaD
Paricalcitol—Oedema—Topiramate—epilepsy syndrome	2.88e-05	0.00017	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP11A1—epilepsy syndrome	2.87e-05	0.000753	CbGpPWpGaD
Paricalcitol—Infection—Topiramate—epilepsy syndrome	2.86e-05	0.000169	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.85e-05	0.000747	CbGpPWpGaD
Paricalcitol—Shock—Topiramate—epilepsy syndrome	2.83e-05	0.000167	CcSEcCtD
Paricalcitol—Diarrhoea—Valproic Acid—epilepsy syndrome	2.82e-05	0.000167	CcSEcCtD
Paricalcitol—Nervous system disorder—Topiramate—epilepsy syndrome	2.82e-05	0.000167	CcSEcCtD
Paricalcitol—Feeling abnormal—Gabapentin—epilepsy syndrome	2.82e-05	0.000166	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.8e-05	0.000165	CcSEcCtD
Paricalcitol—Skin disorder—Topiramate—epilepsy syndrome	2.79e-05	0.000165	CcSEcCtD
Paricalcitol—Hyperhidrosis—Topiramate—epilepsy syndrome	2.78e-05	0.000164	CcSEcCtD
Paricalcitol—Hypersensitivity—Pregabalin—epilepsy syndrome	2.75e-05	0.000162	CcSEcCtD
Paricalcitol—Anorexia—Topiramate—epilepsy syndrome	2.74e-05	0.000162	CcSEcCtD
Paricalcitol—Dizziness—Valproic Acid—epilepsy syndrome	2.73e-05	0.000161	CcSEcCtD
Paricalcitol—Urticaria—Gabapentin—epilepsy syndrome	2.72e-05	0.00016	CcSEcCtD
Paricalcitol—Abdominal pain—Gabapentin—epilepsy syndrome	2.7e-05	0.00016	CcSEcCtD
Paricalcitol—Body temperature increased—Gabapentin—epilepsy syndrome	2.7e-05	0.00016	CcSEcCtD
Paricalcitol—Hypotension—Topiramate—epilepsy syndrome	2.69e-05	0.000159	CcSEcCtD
Paricalcitol—Asthenia—Pregabalin—epilepsy syndrome	2.68e-05	0.000158	CcSEcCtD
Paricalcitol—Pruritus—Pregabalin—epilepsy syndrome	2.64e-05	0.000156	CcSEcCtD
Paricalcitol—Vomiting—Valproic Acid—epilepsy syndrome	2.62e-05	0.000155	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.62e-05	0.000155	CcSEcCtD
Paricalcitol—Insomnia—Topiramate—epilepsy syndrome	2.6e-05	0.000154	CcSEcCtD
Paricalcitol—Rash—Valproic Acid—epilepsy syndrome	2.6e-05	0.000154	CcSEcCtD
Paricalcitol—Dermatitis—Valproic Acid—epilepsy syndrome	2.6e-05	0.000153	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.6e-05	0.000681	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP2D6—epilepsy syndrome	2.59e-05	0.000679	CbGpPWpGaD
Paricalcitol—Headache—Valproic Acid—epilepsy syndrome	2.58e-05	0.000153	CcSEcCtD
Paricalcitol—Paraesthesia—Topiramate—epilepsy syndrome	2.58e-05	0.000152	CcSEcCtD
Paricalcitol—Dyspnoea—Topiramate—epilepsy syndrome	2.57e-05	0.000151	CcSEcCtD
Paricalcitol—Somnolence—Topiramate—epilepsy syndrome	2.56e-05	0.000151	CcSEcCtD
Paricalcitol—Diarrhoea—Pregabalin—epilepsy syndrome	2.55e-05	0.000151	CcSEcCtD
Paricalcitol—Dyspepsia—Topiramate—epilepsy syndrome	2.53e-05	0.000149	CcSEcCtD
Paricalcitol—Hypersensitivity—Gabapentin—epilepsy syndrome	2.52e-05	0.000149	CcSEcCtD
Paricalcitol—VDR—Gene Expression—JUNB—epilepsy syndrome	2.51e-05	0.000657	CbGpPWpGaD
Paricalcitol—Decreased appetite—Topiramate—epilepsy syndrome	2.5e-05	0.000148	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.48e-05	0.000147	CcSEcCtD
Paricalcitol—Fatigue—Topiramate—epilepsy syndrome	2.48e-05	0.000146	CcSEcCtD
Paricalcitol—Dizziness—Pregabalin—epilepsy syndrome	2.47e-05	0.000146	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ADRA2A—epilepsy syndrome	2.47e-05	0.000647	CbGpPWpGaD
Paricalcitol—Constipation—Topiramate—epilepsy syndrome	2.46e-05	0.000145	CcSEcCtD
Paricalcitol—Pain—Topiramate—epilepsy syndrome	2.46e-05	0.000145	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—BCHE—epilepsy syndrome	2.46e-05	0.000644	CbGpPWpGaD
Paricalcitol—Asthenia—Gabapentin—epilepsy syndrome	2.45e-05	0.000145	CcSEcCtD
Paricalcitol—Nausea—Valproic Acid—epilepsy syndrome	2.45e-05	0.000145	CcSEcCtD
Paricalcitol—Pruritus—Gabapentin—epilepsy syndrome	2.42e-05	0.000143	CcSEcCtD
Paricalcitol—Vomiting—Pregabalin—epilepsy syndrome	2.37e-05	0.00014	CcSEcCtD
Paricalcitol—Feeling abnormal—Topiramate—epilepsy syndrome	2.37e-05	0.00014	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ABCG2—epilepsy syndrome	2.37e-05	0.000621	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.35e-05	0.000139	CcSEcCtD
Paricalcitol—Rash—Pregabalin—epilepsy syndrome	2.35e-05	0.000139	CcSEcCtD
Paricalcitol—Dermatitis—Pregabalin—epilepsy syndrome	2.35e-05	0.000139	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—SLC2A1—epilepsy syndrome	2.34e-05	0.000614	CbGpPWpGaD
Paricalcitol—Diarrhoea—Gabapentin—epilepsy syndrome	2.34e-05	0.000138	CcSEcCtD
Paricalcitol—Headache—Pregabalin—epilepsy syndrome	2.34e-05	0.000138	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PLCB1—epilepsy syndrome	2.32e-05	0.000608	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TH—epilepsy syndrome	2.31e-05	0.000605	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP2C19—epilepsy syndrome	2.31e-05	0.000605	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP11A1—epilepsy syndrome	2.29e-05	0.000602	CbGpPWpGaD
Paricalcitol—Urticaria—Topiramate—epilepsy syndrome	2.29e-05	0.000135	CcSEcCtD
Paricalcitol—Abdominal pain—Topiramate—epilepsy syndrome	2.27e-05	0.000134	CcSEcCtD
Paricalcitol—Body temperature increased—Topiramate—epilepsy syndrome	2.27e-05	0.000134	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.27e-05	0.000596	CbGpPWpGaD
Paricalcitol—Dizziness—Gabapentin—epilepsy syndrome	2.26e-05	0.000133	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.24e-05	0.000586	CbGpPWpGaD
Paricalcitol—Nausea—Pregabalin—epilepsy syndrome	2.22e-05	0.000131	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.19e-05	0.000575	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2.18e-05	0.000571	CbGpPWpGaD
Paricalcitol—Vomiting—Gabapentin—epilepsy syndrome	2.17e-05	0.000128	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.16e-05	0.000567	CbGpPWpGaD
Paricalcitol—Rash—Gabapentin—epilepsy syndrome	2.16e-05	0.000127	CcSEcCtD
Paricalcitol—Dermatitis—Gabapentin—epilepsy syndrome	2.15e-05	0.000127	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.15e-05	0.000563	CbGpPWpGaD
Paricalcitol—Headache—Gabapentin—epilepsy syndrome	2.14e-05	0.000126	CcSEcCtD
Paricalcitol—Hypersensitivity—Topiramate—epilepsy syndrome	2.12e-05	0.000125	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CYP2D6—epilepsy syndrome	2.07e-05	0.000543	CbGpPWpGaD
Paricalcitol—Asthenia—Topiramate—epilepsy syndrome	2.06e-05	0.000122	CcSEcCtD
Paricalcitol—Pruritus—Topiramate—epilepsy syndrome	2.04e-05	0.00012	CcSEcCtD
Paricalcitol—Nausea—Gabapentin—epilepsy syndrome	2.03e-05	0.00012	CcSEcCtD
Paricalcitol—VDR—Gene Expression—SIRT1—epilepsy syndrome	2.02e-05	0.000529	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ADRA2A—epilepsy syndrome	1.97e-05	0.000517	CbGpPWpGaD
Paricalcitol—Diarrhoea—Topiramate—epilepsy syndrome	1.97e-05	0.000116	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.97e-05	0.000515	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—BCHE—epilepsy syndrome	1.96e-05	0.000515	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.94e-05	0.000508	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMOX1—epilepsy syndrome	1.93e-05	0.000505	CbGpPWpGaD
Paricalcitol—Dizziness—Topiramate—epilepsy syndrome	1.9e-05	0.000112	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CAT—epilepsy syndrome	1.9e-05	0.000499	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—H2AFX—epilepsy syndrome	1.89e-05	0.000494	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC2A1—epilepsy syndrome	1.87e-05	0.000491	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLCB1—epilepsy syndrome	1.85e-05	0.000486	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCB1—epilepsy syndrome	1.85e-05	0.000485	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TH—epilepsy syndrome	1.85e-05	0.000484	CbGpPWpGaD
Paricalcitol—Vomiting—Topiramate—epilepsy syndrome	1.83e-05	0.000108	CcSEcCtD
Paricalcitol—VDR—Gene Expression—YWHAZ—epilepsy syndrome	1.82e-05	0.000477	CbGpPWpGaD
Paricalcitol—Rash—Topiramate—epilepsy syndrome	1.81e-05	0.000107	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.81e-05	0.000475	CbGpPWpGaD
Paricalcitol—Dermatitis—Topiramate—epilepsy syndrome	1.81e-05	0.000107	CcSEcCtD
Paricalcitol—Headache—Topiramate—epilepsy syndrome	1.8e-05	0.000106	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NR3C1—epilepsy syndrome	1.79e-05	0.000469	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GPX1—epilepsy syndrome	1.72e-05	0.000451	CbGpPWpGaD
Paricalcitol—Nausea—Topiramate—epilepsy syndrome	1.71e-05	0.000101	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—HMOX1—epilepsy syndrome	1.54e-05	0.000404	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAT—epilepsy syndrome	1.52e-05	0.000399	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AGT—epilepsy syndrome	1.51e-05	0.000395	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.5e-05	0.000393	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCB1—epilepsy syndrome	1.48e-05	0.000388	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOE—epilepsy syndrome	1.48e-05	0.000387	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GPX1—epilepsy syndrome	1.37e-05	0.00036	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—POMC—epilepsy syndrome	1.27e-05	0.000333	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AGT—epilepsy syndrome	1.21e-05	0.000316	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOE—epilepsy syndrome	1.18e-05	0.00031	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—epilepsy syndrome	1.16e-05	0.000303	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.14e-05	0.000298	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.14e-05	0.000298	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.14e-05	0.000298	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.14e-05	0.000298	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.14e-05	0.000298	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.14e-05	0.000298	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.04e-05	0.000272	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.04e-05	0.000272	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.04e-05	0.000272	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.04e-05	0.000272	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—POMC—epilepsy syndrome	1.01e-05	0.000266	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—epilepsy syndrome	1.01e-05	0.000265	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—QDPR—epilepsy syndrome	9.66e-06	0.000253	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA4—epilepsy syndrome	9.66e-06	0.000253	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	9.63e-06	0.000253	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—epilepsy syndrome	9.25e-06	0.000243	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—COX3—epilepsy syndrome	9.08e-06	0.000238	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	8.61e-06	0.000226	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PFKL—epilepsy syndrome	8.61e-06	0.000226	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	8.61e-06	0.000226	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	8.61e-06	0.000226	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	8.61e-06	0.000226	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—epilepsy syndrome	8.09e-06	0.000212	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.88e-06	0.000206	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.88e-06	0.000206	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.88e-06	0.000206	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	7.58e-06	0.000199	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GBE1—epilepsy syndrome	7.32e-06	0.000192	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	7.32e-06	0.000192	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.88e-06	0.00018	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.7e-06	0.000176	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NT5E—epilepsy syndrome	6.53e-06	0.000171	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALAD—epilepsy syndrome	6.53e-06	0.000171	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	6.23e-06	0.000163	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	6.23e-06	0.000163	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.09e-06	0.00016	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.97e-06	0.000156	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.85e-06	0.000153	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.75e-06	0.000151	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—epilepsy syndrome	5.48e-06	0.000144	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.37e-06	0.000141	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.22e-06	0.000137	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—epilepsy syndrome	5.09e-06	0.000133	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.72e-06	0.000124	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.72e-06	0.000124	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—epilepsy syndrome	4.07e-06	0.000107	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.85e-06	0.000101	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.75e-06	9.83e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.72e-06	9.77e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.36e-06	8.81e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.2e-06	8.39e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.19e-06	8.36e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.04e-06	7.97e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.01e-06	7.88e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TH—epilepsy syndrome	3e-06	7.86e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.5e-06	6.56e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.47e-06	6.47e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.4e-06	6.29e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.23e-06	5.85e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.96e-06	5.13e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.92e-06	5.03e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.65e-06	4.32e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.5e-06	3.94e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.31e-06	3.44e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.6e-07	1.73e-05	CbGpPWpGaD
